European Medicines Agency authorizes Pfizer vaccine for use in the EU

A healthcare worker holds a coronavirus disease (COVID-19) vaccine vial at Dignity Health Glendale Memorial Hospital and Health Center in Glendale, California, U.S., December 17, 2020.Lucy Nicholson | ReutersThe European Medicines Agency on Monday authorized Pfizer and BioNTech’s coronavirus vaccine for conditional use, opening the door to a inoculation program across the European Union.”EMA has recommended granting a conditional marketing authorisation for the vaccine Comirnaty, developed by BioNTech and Pfizer, to prevent coronavirus disease 2019 (COVID-19) in people from 16 years of age,” the regulator said in a statement.”EMA’s scientific opinion paves the way for the first marketing authorisation of a COVID-19 vaccine in the EU by the European Commission, with all the safeguards, controls and obligations this entails,” the agency said.This is a breaking news story. Please check back for more details.

Show More

Related Articles